Purinergic signaling is important in the development of inflammation associated with neurodegenerative diseases, and several purinergic receptors have emerged as potential therapeutic targets for degenerative diseases of the central nervous system (CNS). The gene discussed is P2RX7; the disease is neurodegenerative disease.